FDA Reverses Course on Moderna's Revised Flu Vax Application

Moderna said on Wednesday the U.S. drug regulator will review its modified flu vaccine application, a week after rejecting the original submission and fueling industry concerns over shifts in the agency's decision-making under the current administration.